05/27/2020
3:34 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2020
3:32 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2020
3:37 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2020
3:35 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
8:11 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2020
3:38 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
8:12 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2020
3:50 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2020
10:01 AM | Crispr Therapeutics (Filer)
| Form D/A
| |
04/09/2020
3:42 PM | Crispr Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
03/12/2020
3:20 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2020
3:20 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2020
3:20 PM | Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2020
3:10 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2020
3:13 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
3:13 PM | Crispr Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2020
2:19 PM | Crispr Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G
| |
02/12/2020
5:02 AM | Crispr Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G
| |
01/29/2020
3:16 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2020
3:09 PM | Bayer Global Investments B.V. (Filed by)
Crispr Therapeutics (Subject)
| Form SC 13D/A
| |
01/10/2020
3:49 PM | Bayer Global Investments B.V. (Filed by)
Crispr Therapeutics (Subject)
| Form SC 13D/A
| |
12/27/2019
3:06 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2019
6:01 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2019
3:05 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2019
3:05 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2019
3:05 PM | Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2019
4:12 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
6:53 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
3:12 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
11/21/2019
3:09 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
3:07 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2019
3:27 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
11/19/2019
7:21 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2019
3:30 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2019
5:35 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2019
5:34 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2019
7:01 AM | Crispr Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2019
6:05 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2019
3:33 PM | Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2019
3:32 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2019
3:23 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2019
3:10 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2019
3:08 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
08/05/2019
4:49 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2019
3:32 PM | Crispr Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/29/2019
3:20 PM | Crispr Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2019
3:05 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2019
3:13 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
3:10 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
1:28 PM | Crispr Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
| Form SC 13D/A
| |
06/26/2019
7:45 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
3:15 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
7:49 PM | Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
7:42 PM | Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2019
4:07 PM | Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:05 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:05 PM | Crispr Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:04 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:04 PM | Crispr Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:44 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
3:16 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:04 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
06/06/2019
4:20 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
3:25 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2019
3:07 PM | Crispr Therapeutics (Filer)
| Form DEFA14A
| |
04/29/2019
3:05 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
6:27 AM | Crispr Therapeutics (Filer)
| Form PRER14A
| |
04/23/2019
1:34 PM | Crispr Therapeutics (Filer)
| Form PRER14A
| |
04/09/2019
3:15 PM | Crispr Therapeutics (Filer)
| Form PRE 14A
| |
03/07/2019
3:17 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:14 PM | Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:14 PM | Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:12 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:11 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:10 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2019
4:32 PM | Crispr Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2019
7:16 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2019
7:15 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2019
9:21 AM | Crispr Therapeutics (Subject)
New Enterprise Associates 15, L.P. (Filed by)
| Form SC 13G/A
| |
01/18/2019
3:32 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4/A
| |
01/10/2019
3:09 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
3:32 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
3:34 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
3:30 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
12/26/2018
3:35 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2018
3:33 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
12/21/2018
4:16 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2018
4:14 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D
| |
12/19/2018
3:22 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
3:29 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
4:29 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
10:08 AM | Crispr Therapeutics (Filer)
| Form CT ORDER
| |
11/07/2018
4:22 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2018
4:25 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2018
7:23 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/24/2018
4:27 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2018
3:16 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2018
3:10 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/19/2018
3:21 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/19/2018
3:02 PM | Crispr Therapeutics (Filer)
| Form S-3ASR
| |
